• Recent Research/Demonstration Projects: A small trial of peri-conceptional PrEP was conducted in Rome examining feasibility, acceptability and tolerability. No trials or demonstration projects of PrEP for horizontal transmission have taken place in Italy.
  • Drug Registration: The European Medicines Agency approved Truvada for PrEP in 2016. The EMA is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union, but each member state will separately determine how, if at all, it might introduce PrEP.
  • Policy/Regulatory: There is no national PrEP policy or guidance at present.
  • Advocacy: Lila and Plus are two activist groups working on PrEP. Plus organized a public PrEP conference in Bologna and conducted surveys on community attitudes toward PrEP.

Last updated on September 1, 2017.

News Spotlight